Sonavex’s multidisciplinary team of surgeons, scientists, technologists and business leaders brings decades of experience in developing, commercializing, and scaling novel medical technologies.
About Sonavex
Rethinking ultrasound
Surgical ultrasound is
Mission
To create novel and automated ultrasound technology that empowers clinicians with actionable data to deliver superior patient care and deliver savings to the healthcare system.
Values
Commitment to Patients & Clinicians
Above all else, we work every day to help clinicians improve the lives of patients
Teamwork & Respect
Our work requires an interdisciplinary team effort and we foster strong teamwork where everyone’s opinions are heard and respected
Creativity & Innovation
We approach hard problems with creative and bold solutions
Integrity & Accountability
We have a high standard of integrity in which each team member works towards our mission and is accountable for their actions
Be the Best
We strive to be the best team, with the best solutions, to deliver superior results for patients
Interdisciplinary collaboration
Technologies created by surgeons
Winner of numerous industry awards
Research supported by federal and state agencies
Our Team
-
David Narrow
Chief Executive OfficerMr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
-
Devin O’Brien Coon, MD, MSE
Co-Founder and PresidentDr. O’Brien Coon is Co-Founder and President, guiding overall company development, clinical and business strategy, and R&D.
-
Alex Yevzlin, MD
Chief Medical OfficerDr. Yevzlin is currently Professor of Medicine and Director of
Interventional Nephrology at the University of Michigan. -
Michelle Zwernemann
VP of Operations, Quality, & StrategyMichelle Zwernemann, MSE, is a biomedical engineer with over 10 years of experience in medical device development and commercialization
-
John Rappe
Chief Business OfficerJohn most recently held the role of CBO for AV Medical Technologies, Ltd where he led all US operations from pre-commercialization to a successful exit to Medtronic.
-
Xin “Ben” Kang, PhD
Director of Research & DevelopmentDr. Xin (Ben) Kang is Director of
Research and Development, overseeing research and product development in addition to invention and exploration of new projects. -
Katy Feeny
Director of Clinical AffairsKaty Feeny is a biomedical engineer with over 10 years of experience in the medical device industry developing and executing clinical research strategies.
Board of Directors
-
Bill Niland
Mr. Niland joined Harpoon Medical as its president and CEO in 2014 and has since sold the company to Edwards Lifesciences for $100M upfront and up to $250M overall.
-
Bob Hallenbeck
Mr. Hallenbeck has spent over 30 years working with inventors, entrepreneurs and university tech transfer offices in developing, funding, licensing and commercializing technology.
-
Jerry Prince, PhD
Dr. Prince is the William B. Kouwenhoven Professor of Computer Engineering, Radiology and Biomedical Engineering at Johns Hopkins University.
-
David Narrow
Mr. Narrow previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy.
-
Devin O’Brien-Coon, MD, MSE
Dr. O’Brien Coon serves as President, guiding overall company development, clinical and business strategy, and R&D.
Advisory Board
-
Randy Cooper, MD
Dr. Randy Cooper joined Southwest Kidney Institute (SKI), a practice with 60 nephrologists throughout Arizona, in 2002 after completing his eight-year tour of duty as a Major in the US Air Force.
-
Terry Litchfield
Terry Litchfield’s role as a
patient advocate began in
the 1970s with her
first job at the National
Kidney Foundation. -
John Ross, MD
Dr. John Ross is widely
recognized as one of the
world’s leading experts in
vascular access.